Key terms

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest NXTC news

Apr 08 11:45am ET Promising Clinical Outlook for NextCure’s Novel ADC LNCB74 Spurs Buy Rating by TipRanks Apr 08 7:10am ET NextCure and LCB present data on B7-H4 antibody drug conjugate at AACR by TipRanks Apr 04 7:16am ET NextCure appoints Rakesh Dixit to Scientific Advisory Board by TipRanks Mar 22 6:17am ET Promising Clinical Trial Results for NextCure’s NC410 Bolster Buy Rating by TipRanks Mar 21 2:30pm ET Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC) by TipRanks Mar 21 9:12am ET NextCure Inc to Engage with Investors in Informal Talks by TipRanks Mar 21 9:03am ET NextCure restructures operations, reduces workforce by 37% by TipRanks Mar 21 9:02am ET NextCure announces intention to partner assets by TipRanks Mar 21 9:01am ET NextCure to prioritize NC410 combo, LNCB74 in 2024 by TipRanks Mar 21 8:56am ET NextCure expects resources to fund operations into 2H26 by TipRanks Mar 21 8:56am ET NextCure reports 2023 EPS ($2.25), consensus ($2.28) by TipRanks Mar 05 6:09pm ET NextCure’s treatment of AML granted FDA orphan designation by TipRanks Mar 05 8:26am ET NextCure publishes preclinical data on function of FLRT3 by TipRanks Jan 22 2:21pm ET Analysts’ Top Healthcare Picks: Ardelyx (ARDX), Generation Bio (GBIO) by TipRanks Jan 18 4:18pm ET NextCure presents preclinical VSTM-1 data by TipRanks

No recent press releases are available for NXTC

NXTC Financials

1-year income & revenue

Key terms

NXTC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NXTC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming